reference/25146880

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25146880

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Journal Article\|Multicenter Study
endingPage	2519
issn	0732-183X 1527-7755
issueIdentifier	15
pageRange	2512-2519
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	2512
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_902f8a86d1b4329196389000bcba8375
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f28caff8c024d7fc14138aecede45303
bibliographicCitation	Fong PC, Yap TA, Boss DS, Carden CP, Mergui-Roelvink M, Gourley C, De Greve J, Lubinski J, Shanley S, Messiou C, A'Hern R, Tutt A, Ashworth A, Stone J, Carmichael J, Schellens JH, de Bono JS, Kaye SB. Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval. J Clin Oncol. 2010 May 20;28(15):2512–9. doi: 10.1200/jco.2009.26.9589. PMID: 20406929.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b1b8cca6d013532240b9a2cb15e1664d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cfbc8d181cb06b9f4da019ea3bb801c0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83f01364e70fe0f36177acc113caa9ba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4307b79a61b6adb83cff0822bb9c486d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aee941350a77930a0001a8c334a7e201 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ebe6fb74e108986acd8f96c93373d4b9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7cacd17e72bc978d583262d6f9ad739f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7be8902e45d276838b872b0089112106 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f4f8a09da44b95075d8d61d265e3488a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9a02a7f283ca8c6cc87affb6005d04d0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6659356cf3c9afaf91119e40fbb116fc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d4215918f63c539d15c0e2fee3ddcd8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4bfa003e46b446e684d511e7ee1ec9a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7607f5cd6a71ed1955a71c7c09bd71c0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2227a923a75d4a3d7ba499489cf80e46 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0549fa846d1797f3ab8d315508214b31 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_242b581746271b2bc52d4dab77442b13 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e1cdce104321a003ca1f52c627e9f5d
date	2010-05-20^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1200/jco.2009.26.9589 https://pubmed.ncbi.nlm.nih.gov/20406929
isPartOf	https://portal.issn.org/resource/ISSN/1527-7755 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 https://portal.issn.org/resource/ISSN/0732-183X
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval
discusses	http://id.nlm.nih.gov/mesh/M0537510 http://id.nlm.nih.gov/mesh/M000601132 http://id.nlm.nih.gov/mesh/M0016766 http://id.nlm.nih.gov/mesh/M0016884 http://id.nlm.nih.gov/mesh/M0017141
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D010879Q000627 http://id.nlm.nih.gov/mesh/D000067856 http://id.nlm.nih.gov/mesh/D010793Q000627 http://id.nlm.nih.gov/mesh/D010051Q000235 http://id.nlm.nih.gov/mesh/D010051Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005185Q000201 http://id.nlm.nih.gov/mesh/D010534Q000201 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D010879Q000009 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D018095 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D010793Q000009 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D019008 http://id.nlm.nih.gov/mesh/D005185Q000473 http://id.nlm.nih.gov/mesh/D005185Q000188 http://id.nlm.nih.gov/mesh/D010534Q000235 http://id.nlm.nih.gov/mesh/D010534Q000188 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D010597 http://id.nlm.nih.gov/mesh/D011065Q000235 http://id.nlm.nih.gov/mesh/D010051Q000201 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D015331 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D005185Q000235 http://id.nlm.nih.gov/mesh/D019398 http://id.nlm.nih.gov/mesh/D010534Q000473 http://id.nlm.nih.gov/mesh/D024522 http://id.nlm.nih.gov/mesh/D010051Q000473
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8752 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f23da35a23be1387249189adc219228a http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8937 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9002f7b62e7223e85a4962c6cd6d9c18 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_533622b82f51bc5431a771c088f3bdd9 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6f3ef4a5ab86c1588ba1fc89f4c730bb http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23725625

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID244484199

Showing number of triples: 1 to 88 of 88.